Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

122.69 +0.80 (+0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,367,382
Open 123.15
Bid (Size) 122.85 (1)
Ask (Size) 123.00 (4)
Prev. Close 121.89
Today's Range 121.68 - 125.50
52wk Range 62.55 - 142.79
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
The COVID-19 pandemic thrust this company's science -- and its stock -- into the spotlight. 
Via The Motley Fool
Exposures COVID-19

Performance

YTD
+9.06%
+9.06%
1 Month
+9.94%
+9.94%
3 Month
+31.00%
+31.00%
6 Month
+76.51%
+76.51%
1 Year
-6.22%
-6.22%

More News

Read More
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Via InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Via FinancialNewsMedia
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
Check Out What Whales Are Doing With MRNA
Via Benzinga
Moderna's Options Frenzy: What You Need to Know
Via Benzinga
Navigating 6 Analyst Ratings For Moderna
Via Benzinga
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Via MarketBeat
Exposures COVID-19
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
Via Benzinga
MSFT Analysis: Why Microsoft Stock Is a Must-Own for Investors in 2024
Via InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Via InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
Why Moderna Stock Blasted 13% Higher Today
Via The Motley Fool
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
Via Benzinga
Topics Economy
Exposures Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Via Benzinga
Exposures COVID-19
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Via Investor's Business Daily
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks
Via InvestorPlace
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.